NORTH AMERICA DNA VACCINES MARKET 2019-2027

Lifesciences | Pharmaceuticals

NORTH AMERICA DNA VACCINES MARKET 2019-2027

Market By Type, Application, Technology And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton Market Research forecasts the North America DNA vaccines market to progress during the forecast period of 2019-2027 at a CAGR of 42.49%, in terms of revenue.

The countries that have been scrutinized in the North America DNA vaccines market are:

•           The United States

•           Canada

The North America DNA vaccines market is developing and expanding at a rapid pace. The advancing growth of the North America market can be primarily attributed to the enhancement in the prevalence of chronic and infectious diseases in humans and animals. DNA vaccines are introduced for the prevention of diseases such as HIV, HPV, cardiovascular diseases, measles and those foot & mouth diseases that are most prevalent in animals. The market in North America is also on the verge of growth and development due to the rise in the amount of veterinary expenditure & investments made by the government and health institutions. The establishment and presence of various clinical research and testing laboratories in countries like the United States and Canada are paving the way for future opportunities for the DNA vaccines market.

North America DNA vaccines market to progress during the forecast period of 2019-2027 at a CAGR of 42.49%, in terms of revenue.

We provide additional customization based on your specific requirements. Request For Customization

The DNA vaccines market in Canada is burgeoning, and it is majorly driven by the rising veterinary expenditure and investments made by the country’s government for increased R&D activities. The constant innovations and development of these vaccines for the prevention of chronic and infectious diseases are also contributing to the market growth. According to the National Center for Biotechnology Information, the Canadian government made an investment of $440 million in 2015 for the advancement and development of DNA vaccines in the country, focusing on both, the humans and animals. As per the government, in the present scenario, 73% of the population has pets in their household, which mostly includes dogs and cats. The prevention of chronic and infectious diseases in pets is creating growth opportunities for the DNA vaccines market in the country.

Eli Lilly and Company is a multinational healthcare company based in the United States. It is engaged in the manufacturing, discovery, development and sales of pharmaceutical products for humans and animals around the world. The company’s products include endocrine, neuroscience, anti-affective, oncology and cardiovascular agents, as well as animal healthcare products. At the end of 2016, the company achieved a revenue of around $21,222.1 million.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    NORTH AMERICA DNA VACCINES MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES OUTLOOK

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREATS OF SUBSTITUTE PRODUCT

2.2.3.   BARGAINING POWER OF BUYER

2.2.4.   BARGAINING POWER OF SUPPLIER

2.2.5.   INTENSITY OF COMPETITIVE RIVALRY

2.3. VENDOR SCORECARD

2.4. VALUE CHAIN OUTLOOK

2.5. KEY INSIGHTS

2.6. REGULATORY FRAMEWORK

2.7. KEY BUYING OUTLOOK

2.8. MARKET DRIVERS

2.8.1.   SURGE IN NEW VACCINE DEVELOPMENT

2.8.2.   RISE IN THE USAGE OF DNA VACCINES FOR ANIMAL HEALTHCARE

2.8.3.   RISING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES

2.9. MARKET RESTRAINTS

2.9.1.   LACK OF LEGAL AND ETHICAL FRAMEWORK

2.9.2.   STRINGENT GOVERNMENT REGULATIONS

2.10.            MARKET OPPORTUNITIES

2.10.1.                GROWING DEMAND FOR GENE THERAPY

2.10.2.                STEADY VACCINES ARE EASY TO STORE AND TRANSPORT

2.10.3.                INCREASING NUMBER OF CLINICAL TRIALS ON HUMANS

2.11.            MARKET CHALLENGES

2.11.1.                VARIATION IN THE REGULATORY PATHWAY AND THE POINTS OF CONSIDERATION REGARDING ENVIRONMENTAL VALUATION

3.    DNA VACCINES MARKET OUTLOOK - BY TYPE

3.1. ANIMAL DNA VACCINE

3.2. HUMAN DNA VACCINE

4.    DNA VACCINES MARKET OUTLOOK - BY APPLICATION

4.1. HUMAN DISEASE

4.2. VETERINARY DISEASE

5.    DNA VACCINES MARKET OUTLOOK - BY TECHNOLOGY

5.1. PLASMID DNA VACCINES

5.2. PLASMID DNA DELIVERY

6.    DNA VACCINES MARKET OUTLOOK - BY REGION

6.1. NORTH AMERICA

6.1.1.   COUNTRY ANALYSIS

6.1.1.1.      THE UNITED STATES

6.1.1.2.      CANADA

7.    COMPETITIVE LANDSCAPE

7.1. ASTELLAS PHARMA, INC.

7.2. DENDREON CORPORATION (ACQUIRED BY SANPOWER GROUP)

7.3. ELI LILLY AND COMPANY

7.4. EUROGENTEC S.A.

7.5. GLAXOSMITHKLINE, INC.

7.6. INOVIO PHARMACEUTICALS, INC.

7.7. MADISON VACCINES, INCORPORATED (MVI)

7.8. MERCK & CO.

7.9. MERIAL LIMITED (ACQUIRED BY BOEHRINGER INGELHEIM)

7.10.            NOVARTIS AG

7.11.            SANOFI

7.12.            VGXI

7.13.            VICAL, INCORPORATED

7.14.            XENETIC BIOSCIENCES, INC.

7.15.            ZOETIS, INC.

8.    METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of table

TABLE 1        NORTH AMERICA DNA VACCINES MARKET 2019-2027 ($ MILLION)

TABLE 2        INTERVENTION AND PHASE OF SOME DISEASES/CONDITIONS

TABLE 3        REGULATIONS TO FOLLOW BEFORE COMMERCIALIZATION

TABLE 4        TEMPERATURE REQUIREMENT IN PRESERVATION FOR VARIOUS VACCINES

TABLE 5        APPROACHES BEING TESTED TO ENHANCE THE LOW IMMUNOGENICITY

TABLE 6        CLINICAL TRIALS ON HUMANS INVOLVING DNA VACCINES

TABLE 7        NORTH AMERICA DNA VACCINES MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 8        NORTH AMERICA DNA VACCINES MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 9        NORTH AMERICA DNA VACCINES MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)

TABLE 10      NORTH AMERICA DNA VACCINES MARKET BY COUNTRY 2019-2027 ($ MILLION)

List of Figures

FIGURE 1      NORTH AMERICA DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 2      VALUE CHAIN ANALYSES FOR DNA VACCINE INDUSTRY

FIGURE 3      NORTH AMERICA DNA VACCINES MARKET IN VETERINARY DISEASES 2019-2027 ($ MILLION)

FIGURE 4      CLINICAL TRIALS OF GENE THERAPY

FIGURE 5      NORTH AMERICA DNA VACCINES MARKET IN ANIMAL DNA VACCINES 2019-2027 ($ MILLION)

FIGURE 6      NORTH AMERICA DNA VACCINES MARKET IN HUMAN DNA VACCINES 2019-2027 ($ MILLION)

FIGURE 7      NORTH AMERICA DNA VACCINES MARKET SHARE BY APPLICATION 2017 & 2026 (%)

FIGURE 8      NORTH AMERICA DNA VACCINES MARKET IN HUMAN DISEASES 2019-2027 ($ MILLION)

FIGURE 9      NORTH AMERICA DNA VACCINES MARKET IN VETERINARY DISEASES 2019-2027 ($ MILLION)

FIGURE 10   NORTH AMERICA DNA VACCINES MARKET IN PLASMID DNA VACCINES TECHNOLOGY 2019-2027 ($ MILLION)

FIGURE 11   NORTH AMERICA DNA VACCINES MARKET IN PLASMID DNA DELIVERY TECHNOLOGY 2019-2027 ($ MILLION)

FIGURE 12   THE UNITED STATES DNA VACCINES MARKET 2019-2027 ($ MILLION)

FIGURE 13   CANADA DNA VACCINES MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;